The diagnosis of osteoporosis.

PubWeight™: 10.90‹?› | Rank: Top 0.1%

🔗 View Article (PMID 7976495)

Published in J Bone Miner Res on August 01, 1994

Authors

J A Kanis1, L J Melton, C Christiansen, C C Johnston, N Khaltaev

Author Affiliations

1: WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, England.

Associated clinical trials:

The Effects of Fragility Fracture Integrated Rehabilitation Management | NCT04760756

Articles citing this

(truncated to the top 100)

2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ (2002) 9.89

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44

European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27

Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int (2014) 5.17

European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88

Bone densitometry in clinical practice. BMJ (1995) 3.48

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74

Relationship of obesity with osteoporosis. J Clin Endocrinol Metab (2007) 2.71

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract (2011) 2.29

Comparative study of axial and femoral bone mineral density and parameters of mandibular bone quality in patients receiving dental implants. Osteoporos Int (2006) 2.01

A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest (2001) 1.98

NCCN Task Force Report: Bone Health in Cancer Care. J Natl Compr Canc Netw (2009) 1.97

Clinical risk factors as predictors of postmenopausal osteoporosis in general practice. Br J Gen Pract (2001) 1.73

Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet (2009) 1.73

Effect of osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of osteoporosis in elderly men and women. Osteoporos Int (1997) 1.71

Skeletal health after continuation, withdrawal, or delay of alendronate in men with prostate cancer undergoing androgen-deprivation therapy. J Clin Oncol (2008) 1.68

Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy? Clin Orthop Relat Res (2010) 1.68

Moderate alcohol intake lowers biochemical markers of bone turnover in postmenopausal women. Menopause (2012) 1.63

Infrared assessment of bone quality: a review. Clin Orthop Relat Res (2011) 1.63

Reduced bone density in patients with inflammatory bowel disease. Gut (1997) 1.56

Correlations of dual-energy X-ray absorptiometry, quantitative computed tomography, and single photon absorptiometry with spinal and non-spinal fractures. Osteoporos Int (1996) 1.55

Lower vitamin E serum levels are associated with osteoporosis in early postmenopausal women: a cross-sectional study. J Bone Miner Metab (2013) 1.55

Association between vitamin K intake from fermented soybeans, natto, and bone mineral density in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) study. Osteoporos Int (2011) 1.50

Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia. Aging Clin Exp Res (2015) 1.49

Copy number variation of the APC gene is associated with regulation of bone mineral density. Bone (2012) 1.46

Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos Int (2008) 1.45

Association of MTHFR C667T polymorphism with bone mineral density and fracture risk: an updated meta-analysis. Osteoporos Int (2011) 1.42

Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool. J Bone Miner Res (2010) 1.42

Updated fracture incidence rates for the US version of FRAX. Osteoporos Int (2009) 1.40

UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos (2017) 1.40

Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders. Osteoporos Int (2016) 1.38

Sex-hormone-binding globulin is negatively correlated with femoral bone-mineral density in male cardiac-transplant recipients. Wien Klin Wochenschr (2004) 1.38

The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA. Osteoporos Int (2016) 1.37

Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int (2011) 1.33

Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine (Baltimore) (2012) 1.31

Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body. Osteoporos Int (2004) 1.31

Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. Ann Rheum Dis (2004) 1.30

Effect of low-intensity back exercise on quality of life and back extensor strength in patients with osteoporosis: a randomized controlled trial. Osteoporos Int (2007) 1.30

The assessment of fracture risk. J Bone Joint Surg Am (2010) 1.27

Transcriptional regulation of bone formation by the osteoblast-specific transcription factor Osx. J Orthop Surg Res (2010) 1.27

Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporos Int (2010) 1.27

Compositional breast imaging using a dual-energy mammography protocol. Med Phys (2010) 1.26

Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int (2010) 1.25

Assessing fracture risk using gradient boosting machine (GBM) models. J Bone Miner Res (2012) 1.24

Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis. Ann Rheum Dis (2003) 1.22

Distal humerus fractures in elderly patients: results after open reduction and internal fixation. Osteoporos Int (2004) 1.22

Health-related quality of life in patients with osteopenia or osteoporosis with and without fractures in a geriatric rehabilitation department. Wien Med Wochenschr (2009) 1.20

FRAX assessment of osteoporotic fracture probability in Switzerland. Osteoporos Int (2009) 1.19

Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther (2008) 1.19

Normative data of bone Mineral Density in healthy population of Tehran, Iran: a cross sectional study. BMC Musculoskelet Disord (2005) 1.18

Osteoporosis assessment by whole body region vs. site-specific DXA. Osteoporos Int (2005) 1.17

Age-related changes in cortical porosity of the midshaft of the human femur. J Anat (1997) 1.16

Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA). Osteoporos Int (2004) 1.15

Bone disease in patients with primary sclerosing cholangitis. Gastroenterology (2010) 1.15

Vertebral size in elderly women with osteoporosis. Mechanical implications and relationship to fractures. J Clin Invest (1995) 1.15

Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int (2005) 1.15

Ankylosing spondylitis and bone mineral density--what is the ideal tool for measurement? Rheumatol Int (2004) 1.14

The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005-2008. Osteoporos Int (2011) 1.14

The assessment of osteoporosis risk factors in Iranian women compared with Indian women. BMC Musculoskelet Disord (2008) 1.13

Relationship between bone mineral density and myocardial infarction in US adults. Osteoporos Int (2005) 1.13

Assessment of trabecular bone structure comparing magnetic resonance imaging at 3 Tesla with high-resolution peripheral quantitative computed tomography ex vivo and in vivo. Osteoporos Int (2007) 1.12

Prevention of osteoporosis-related fractures among postmenopausal women and older men. CMAJ (2009) 1.12

Morphology, localization and accumulation of in vivo microdamage in human cortical bone. Bone (2006) 1.11

Approach to the prostate cancer patient with bone disease. J Clin Endocrinol Metab (2008) 1.11

Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls. Dig Dis Sci (2005) 1.11

Quality of life assessments with SF 36 in different musculoskeletal diseases. Clin Rheumatol (2007) 1.09

Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int (2004) 1.09

Comparison of QCT and DXA: Osteoporosis Detection Rates in Postmenopausal Women. Int J Endocrinol (2013) 1.08

Effect of a gluten free diet on osteopenia in adults with newly diagnosed coeliac disease. Gut (1996) 1.08

Association of oestrogen receptor alpha gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone. J Med Genet (2005) 1.08

Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women. Osteoporos Int (2003) 1.07

The long-term predictive value of bone mineral density measurements for fracture risk is independent of the site of measurement and the age at diagnosis: results from the Prospective Epidemiological Risk Factors study. Osteoporos Int (2005) 1.06

Prospective study of bone mineral density changes in aging men with or at risk for HIV infection. AIDS (2010) 1.06

Treatment of osteoporosis in men. Bone (2012) 1.06

The clinical epidemiology of male osteoporosis: a review of the recent literature. Clin Epidemiol (2015) 1.05

A referent bone mineral density database for Chinese American women. Osteoporos Int (2006) 1.05

Searching for osteoporosis genes in the post-genome era: progress and challenges. Osteoporos Int (2003) 1.05

Effects of calcium intake, milk and dairy product intake, and blood vitamin D level on osteoporosis risk in Korean adults: analysis of the 2008 and 2009 Korea National Health and Nutrition Examination Survey. Nutr Res Pract (2013) 1.05

Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper. Osteoporos Int (2012) 1.05

Factor analysis of biochemical markers associated with bone mineral density in adults. J Phys Ther Sci (2014) 1.05

Reproducibility of bone mineral density measurement in daily practice. Ann Rheum Dis (2004) 1.05

Premenopausal women and low bone density. Can Fam Physician (2006) 1.05

Risk assessment and screening for low bone mineral density in a multi-ethnic population of women and men: does one approach fit all? Osteoporos Int (2003) 1.05

High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut (2002) 1.04

Estrogen receptor α36 mediates a bone-sparing effect of 17β-estrodiol in postmenopausal women. J Bone Miner Res (2011) 1.04

Height loss, vertebral fractures, and the misclassification of osteoporosis. Bone (2010) 1.04

Prevalence of osteoporosis in patients requiring spine surgery: incidence and significance of osteoporosis in spine disease. Osteoporos Int (2007) 1.03

Ovariectomy-associated changes in bone mineral density and bone marrow haematopoiesis in rats. Int J Exp Pathol (2009) 1.03

Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol (2010) 1.02

Resveratrol mediated modulation of Sirt-1/Runx2 promotes osteogenic differentiation of mesenchymal stem cells: potential role of Runx2 deacetylation. PLoS One (2012) 1.02

Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative data. J Natl Med Assoc (2005) 1.02

Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax (2004) 1.02

Correlation of plain radiographic indices of the hip with quantitative bone mineral density. Osteoporos Int (2007) 1.01

Comparison between various fracture risk assessment tools. Osteoporos Int (2014) 1.00

Reference values of bone mineral density and prevalence of osteoporosis in Chinese adults. Osteoporos Int (2013) 1.00

Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study. Osteoporos Int (2004) 0.99

Shortcomings of DXA to assess changes in bone tissue density and microstructure induced by metabolic bone diseases in rat models. Osteoporos Int (2008) 0.99

Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 2. The use of bone density measurement in the diagnosis and management of osteoporosis. CMAJ (1996) 0.99

Vertebral body stenting: a new method for vertebral augmentation versus kyphoplasty. Eur Spine J (2010) 0.99

Articles by these authors

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA (1999) 9.71

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43

Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med (1994) 9.25

Hip fractures in the elderly: a world-wide projection. Osteoporos Int (1992) 9.08

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

Involutional osteoporosis. N Engl J Med (1986) 8.20

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62

Psychotropic drug use and the risk of hip fracture. N Engl J Med (1987) 7.53

Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol (2001) 7.27

Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int (1998) 7.14

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med (1997) 6.15

Bacterial genome sizes determined by DNA renaturation studies. J Gen Microbiol (1970) 5.86

The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76

Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res (1997) 5.69

Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med (1990) 5.49

Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) (1982) 5.29

A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis (1992) 5.22

Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA (1996) 5.17

A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92

Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84

Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res (1992) 4.75

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 4.74

Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71

Age and bone mass as predictors of fracture in a prospective study. J Clin Invest (1988) 4.46

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28

A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res (1998) 4.24

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18

Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16

Potential effect of authorization bias on medical record research. Mayo Clin Proc (1999) 4.01

Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90

The prevention and treatment of osteoporosis. N Engl J Med (1992) 3.90

Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res (2000) 3.86

Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60

Thoracic aortic aneurysms: a population-based study. Surgery (1982) 3.36

Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34

Serological cross-reactions between Mycoplasma genitalium and Mycoplasma pneumoniae. J Clin Microbiol (1984) 3.15

Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08

Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis (1979) 3.06

Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int (2011) 3.04

Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98

Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation (1989) 2.94

Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Relat Res (1981) 2.93

Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92

Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89

Genome size of mycoplasmal DNA. Nature (1969) 2.86

Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85

Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone (2001) 2.81

Epidemiologic features of humeral fractures. Clin Orthop Relat Res (1982) 2.79

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77

Prediction of rapid bone loss in postmenopausal women. Lancet (1987) 2.76

Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74

Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72

Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70

Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial. Br Med J (1973) 2.60

Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54

Screening for osteoporosis. Ann Intern Med (1990) 2.52

Long-term survival of a cohort of community residents with asthma. N Engl J Med (1994) 2.47

Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups. JAMA (1997) 2.46

Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab (2001) 2.43

Osteopetrosis. A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form. Medicine (Baltimore) (1968) 2.39

Bone-density measurement. Lancet (1992) 2.38

Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res (1999) 2.37

Osteoporosis and the risk of hip fracture. Am J Epidemiol (1986) 2.35

Genetic factors in determining bone mass. J Clin Invest (1973) 2.35

Letter: Anticonvulsant hypomagnesaemia. Br Med J (1974) 2.30

Baseline measurement of bone mass predicts fracture in white women. Ann Intern Med (1989) 2.30

A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27

Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol (1989) 2.24

World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl (1994) 2.23

Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med (1982) 2.23

Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology (2007) 2.22

Vitamin D and bone health in the elderly. Am J Clin Nutr (1982) 2.21

Evidence for two distinct syndromes of involutional osteoporosis. Am J Med (1983) 2.17

Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology (1992) 2.17

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17

Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc (2001) 2.17

Incidence of Colles' fracture in a North American community. Am J Public Health (1982) 2.17

Outcomes of surgery in patients 90 years of age and older. JAMA (1989) 2.15

A family history of fracture and fracture risk: a meta-analysis. Bone (2004) 2.13

Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res (1995) 2.12

Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ (1991) 2.12

Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology (1994) 2.12

Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 2.11

Trends in the utilization of primary total hip arthroplasty, 1969 through 1990: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc (1993) 2.10

Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology (1990) 2.09

Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab (2000) 2.09

Complications leading to surgery after breast implantation. N Engl J Med (1997) 2.05

Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut (2001) 2.05

Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest (1980) 2.04

Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. N Engl J Med (1987) 2.03

Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol (1996) 2.01

Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest (1986) 2.01